Alexopoulou D, Kontos C, Christodoulou S, Papadopoulos I, Scorilas A. Kallikrein-related peptidase 11 (KLK11) mRNA expression predicts short-term relapse and poor overall survival in colorectal cancer patients: Kontos, Christos. Clinical Chemistry and Laboratory Medicine. 2014;52.

Rapti S, Kontos C, Christodoulou S, Papadopoulos I, Scorilas A. 5-miR-96: a novel molecular tissue biomarker predicting unfavorable outcome in colorectal cancer patients: Brattsand, Maria. Clinical Chemistry and Laboratory Medicine. 2014;52.

Kontos C, Alexopoulou D, Christodoulou S, Papadopoulos I, Scorilas A. 3-Kallikrein-related peptidase 6 (KLK6) mRNA expression: an independent unfavorable prognosticator in colon cancer: Brattsand, Maria. Clinical Chemistry and Laboratory Medicine. 2014;52.

Adamopoulos P, Kontos C, Rapti S, Christodoulou S, Papadopoulos I, Scorilas A. 1-Enhanced miR224 transcription predicts short-term relapse and poor overall survival in colorectal adenocarcinoma patients: Kontos, Christos. Clinical Chemistry and Laboratory Medicine. 2014;52.

Kontos C, Rapti S, Christodoulou S, Papadopoulos I, Scorilas A. 4-miR-34a overexpression is a strong indicator of unfavorable survival outcome in colon cancer patients: Brattsand, Maria. Clinical Chemistry and Laboratory Medicine. 2014;52.

Christodoulou S, Alexopoulou DK, Kontos CK, Scorilas A, Papadopoulos IN. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma. Tumor Biology. 2014;35:4673–4685.

Koumarianou A, Christodoulou M-I, Patapis P, Papadopoulos I, Liakata E, Giagini A, Stavropoulou A, Poulakaki N, Tountas N, Xiros N, et al. The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Experimental hematology & oncology. 2014;3:1–10.

Rapti S-M, Kontos CK, Papadopoulos IN, Scorilas A. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clinical Chemistry and Laboratory Medicine (CCLM). 2014;52:1217–1227.

Alexopoulou DK, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. Biomarkers in medicine. 2014;8:671–685.

Vernadakis S, Moris D, Papadopoulos IN. Acute abdominal pain due to intussusception of the small intestine in a 17-year-old patient. Surgery. 2014;156:1282–1283.

Rapti S-M, Kontos CK, Papadopoulos IN, Scorilas A. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clinical Chemistry and Laboratory Medicine [Internet]. 2014;52:1217-1227. Website

Koumarianou A, Christodoulou M-I, Patapis P, Papadopoulos I, Liakata E, Giagini A, Stavropoulou A, Poulakaki N, Tountas N, Xiros N, et al. The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Experimental Hematology and Oncology [Internet]. 2014;3. Website

Alexopoulou DK, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. Biomarkers in Medicine [Internet]. 2014;8:671-685. Website

Christodoulou S, Alexopoulou DK, Kontos CK, Scorilas A, Papadopoulos IN. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma. Tumor Biology [Internet]. 2014;35:4673-4685. Website

Vernadakis S, Moris D, Papadopoulos IN. Acute abdominal pain due to intussusception of the small intestine in a 17-year-old patient. Surgery (United States) [Internet]. 2014;156:1282-1283. Website

Vernadakis S, Moris D, Papadopoulos IN. Acute abdominal pain due to intussusception of the small intestine in a 17-year-old patient. Surgery (United States). 2014;156:1282-1283.

Rapti S-M, Kontos CK, Papadopoulos IN, Scorilas A. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clinical Chemistry and Laboratory Medicine. 2014;52:1217-1227.

Alexopoulou DK, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. Biomarkers in Medicine. 2014;8:671-685.

Christodoulou S, Alexopoulou DK, Kontos CK, Scorilas A, Papadopoulos IN. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma. Tumor Biology. 2014;35:4673-4685.

Koumarianou A, Christodoulou M-I, Patapis P, Papadopoulos I, Liakata E, Giagini A, Stavropoulou A, Poulakaki N, Tountas N, Xiros N, et al. The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients. Experimental Hematology and Oncology. 2014;3.